Literature DB >> 34903673

QnAs with Katalin Karikó.

Prashant Nair.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34903673      PMCID： PMC8713962          DOI： 10.1073/pnas.2119757118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  9 in total

1.  Foreign nucleic acids as the stimulus to make interferon.

Authors:  A ISAACS; R A COX; Z ROTEM
Journal:  Lancet       Date:  1963-07-20       Impact factor: 79.321

2.  Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.

Authors:  Katalin Karikó; Michael Buckstein; Houping Ni; Drew Weissman
Journal:  Immunity       Date:  2005-08       Impact factor: 31.745

3.  Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.

Authors:  Katalin Karikó; Hiromi Muramatsu; Frank A Welsh; János Ludwig; Hiroki Kato; Shizuo Akira; Drew Weissman
Journal:  Mol Ther       Date:  2008-09-16       Impact factor: 11.454

Review 4.  mRNA-based therapeutics--developing a new class of drugs.

Authors:  Ugur Sahin; Katalin Karikó; Özlem Türeci
Journal:  Nat Rev Drug Discov       Date:  2014-09-19       Impact factor: 84.694

5.  Liposome mediated DNA-transfer into mammalian cells.

Authors:  G Somlyai; E Kondorosi; K Karikó; E G Duda
Journal:  Acta Biochim Biophys Acad Sci Hung       Date:  1985

6.  BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

Authors:  Ugur Sahin; Alexander Muik; Isabel Vogler; Evelyna Derhovanessian; Lena M Kranz; Mathias Vormehr; Jasmin Quandt; Nicole Bidmon; Alexander Ulges; Alina Baum; Kristen E Pascal; Daniel Maurus; Sebastian Brachtendorf; Verena Lörks; Julian Sikorski; Peter Koch; Rolf Hilker; Dirk Becker; Ann-Kathrin Eller; Jan Grützner; Manuel Tonigold; Carsten Boesler; Corinna Rosenbaum; Ludwig Heesen; Marie-Cristine Kühnle; Asaf Poran; Jesse Z Dong; Ulrich Luxemburger; Alexandra Kemmer-Brück; David Langer; Martin Bexon; Stefanie Bolte; Tania Palanche; Armin Schultz; Sybille Baumann; Azita J Mahiny; Gábor Boros; Jonas Reinholz; Gábor T Szabó; Katalin Karikó; Pei-Yong Shi; Camila Fontes-Garfias; John L Perez; Mark Cutler; David Cooper; Christos A Kyratsous; Philip R Dormitzer; Kathrin U Jansen; Özlem Türeci
Journal:  Nature       Date:  2021-05-27       Impact factor: 49.962

7.  Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination.

Authors:  Norbert Pardi; Michael J Hogan; Rebecca S Pelc; Hiromi Muramatsu; Hanne Andersen; Christina R DeMaso; Kimberly A Dowd; Laura L Sutherland; Richard M Scearce; Robert Parks; Wendeline Wagner; Alex Granados; Jack Greenhouse; Michelle Walker; Elinor Willis; Jae-Sung Yu; Charles E McGee; Gregory D Sempowski; Barbara L Mui; Ying K Tam; Yan-Jang Huang; Dana Vanlandingham; Veronica M Holmes; Harikrishnan Balachandran; Sujata Sahu; Michelle Lifton; Stephen Higgs; Scott E Hensley; Thomas D Madden; Michael J Hope; Katalin Karikó; Sampa Santra; Barney S Graham; Mark G Lewis; Theodore C Pierson; Barton F Haynes; Drew Weissman
Journal:  Nature       Date:  2017-02-02       Impact factor: 49.962

8.  Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses.

Authors:  Kapil Bahl; Joe J Senn; Olga Yuzhakov; Alex Bulychev; Luis A Brito; Kimberly J Hassett; Michael E Laska; Mike Smith; Örn Almarsson; James Thompson; Amilcar Mick Ribeiro; Mike Watson; Tal Zaks; Giuseppe Ciaramella
Journal:  Mol Ther       Date:  2017-04-27       Impact factor: 12.910
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.